Publications

Department of Medicine faculty members published more than 3,600 peer-reviewed articles in 2024.

Antiviral therapy

Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts.

2002

Authors: Fischer M, Wong JK, Russenberger D, Joos B, Opravil M, Hirschel B, Trkola A, Kuster H, Weber R, Günthard HF

Molecular therapy : the journal of the American Society of Gene Therapy

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

2002

Authors: Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM

Journal of immunology (Baltimore, Md. : 1950)

The mechanism underlying T cell help for induction of an antigen-specific in vivo humoral immune response to intact Streptococcus pneumoniae is dependent on the type of antigen.

2002

Authors: Wu ZQ, Shen Y, Khan AQ, Chu CL, Riese R, Chapman HA, Kanagawa O, Snapper CM

Clinical nuclear medicine

Tc-99m sulfur colloid and Tc-99m tagged red blood cell methods are comparable for detecting lower gastrointestinal bleeding in clinical practice.

2002

Authors: Ponzo F, Zhuang H, Liu FM, Lacorte LB, Moussavian B, Wang S, Alavi A

The Journal of physiology

Localization of aquaporin-5 in sweat glands and functional analysis using knockout mice.

2002

Authors: Song Y, Sonawane N, Verkman AS

Journal of anatomy

Aquaporin water channels and endothelial cell function.

2002

Authors: Verkman AS

The Journal of general physiology

Aquaporin deletion in mice reduces intraocular pressure and aqueous fluid production.

2002

Authors: Zhang D, Vetrivel L, Verkman AS

Journal of cardiac failure

Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?

2002

Authors: Teerlink JR

Arteriosclerosis, thrombosis, and vascular biology

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.

2002

Authors: Herrington DM, Vittinghoff E, Howard TD, Major DA, Owen J, Reboussin DM, Bowden D, Bittner V, Simon JA, Grady D, Hulley SB

The Journal of invasive cardiology

Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.

2002

Authors: Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM